VCYT Veracyte Inc
Which ETFs hold VCYT? Veracyte Inc is held by 2 funds tracked by ETFpeek.
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Currently Held By
Insider Activity
last 90 days| Date | Person | Action | Plan | Shares | Value | Score |
|---|---|---|---|---|---|---|
| 27 Oct 2026 | Karin Eastham Director / Other | SELL | Unknown | 14,850 | $743K | 60 |
| Date | Person | Action | Plan | Shares | Value | Score |
|---|---|---|---|---|---|---|
| 28 Oct 2026 | Jonathan Wygant VP & Chief Accounting Officer | SELL | Vested (RSU) | 1,306 | $66K | 30 |
| 27 Oct 2026 | Karin Eastham Director / Other | SELL | Unknown | 14,850 | $743K | 60 |
| 27 Oct 2026 | Jens Holstein Director / Other | SELL | Unknown | 7,500 | $375K | 30 |
| 27 Oct 2026 | Jens Holstein Director / Other | BUY | Option Exercise | 7,500 | $265K | 0 |
| 27 Oct 2026 | Karin Eastham Director / Other | BUY | Option Exercise | 10,000 | $270K | 0 |
| 19 Oct 2026 | Muna Bhanji Director / Other | SELL | Unknown | 1,864 | $81K | 0 |
| 21 Sep 2026 | John Leite Global Chief Commercial Officer | SELL | Unknown | 4,015 | $161K | 0 |
Trade History
25 trades| Date | Fund | Direction | Shares Changed | % Δ ETF | % Δ Position |
|---|---|---|---|---|---|
| 7 Oct 2026 | ARKG | BUYAdded | +389,516 | +0.84% | 24.62% |
| 6 Oct 2026 | ARKG | BUYAdded | +115,462 | +0.21% | 9.53% |
| 2 Oct 2026 | ARKK | BUYAdded | +159,319 | +0.05% | 7.91% |
| 1 Oct 2026 | ARKK | BUYAdded | +76,362 | +0.05% | 4.58% |
| 30 Sep 2026 | ARKK | BUYAdded | +119,449 | +0.08% | 7.74% |
| 24 Sep 2026 | ARKG | BUYAdded | +20,905 | +0.13% | 2.01% |
| 23 Sep 2026 | ARKG | BUYAdded | +12,579 | +0.08% | 1.18% |
| 22 Sep 2026 | ARKG | BUYAdded | +74,881 | +0.21% | 7.23% |
| 8 Sep 2026 | ARKK | BUYAdded | +22,148 | -0.02% | 1.80% |
| 1 Sep 2026 | ARKG | BUYAdded | +7,031 | +0.02% | 0.72% |
| 31 Aug 2026 | ARKK | BUYAdded | +161,228 | +0.11% | 13.61% |
| 31 Aug 2026 | ARKG | BUYAdded | +51,841 | +0.11% | 5.34% |
| 28 Aug 2026 | ARKK | BUYAdded | +36,111 | +0.02% | 3.49% |
| 28 Aug 2026 | ARKG | BUYAdded | +11,678 | +0.06% | 1.27% |
| 29 Jul 2026 | ARKK | SELLReduced | -20,521 | -0.05% | 1.97% |
| 9 Jul 2026 | ARKG | SELLReduced | -67,470 | -0.18% | 7.34% |
| 8 Jul 2026 | ARKG | SELLReduced | -12,424 | -0.07% | 1.32% |
| 2 Jul 2026 | ARKK | SELLReduced | -55,680 | -0.05% | 4.81% |
| 1 Jul 2026 | ARKK | SELLReduced | -53,991 | -0.11% | 4.53% |
| 16 Jun 2026 | ARKK | SELLReduced | -166,229 | -0.16% | 10.94% |
| 15 Jun 2026 | ARKK | SELLReduced | -62,701 | -0.05% | 2.18% |
| 12 Jun 2026 | ARKK | SELLReduced | -55,081 | -0.07% | 2.90% |
| 11 Jun 2026 | ARKK | SELLReduced | -143,289 | -0.09% | 8.17% |
| 5 Jun 2026 | ARKK | SELLReduced | -28,496 | -0.01% | 1.65% |
| 4 Jun 2026 | ARKK | SELLReduced | -112,072 | -0.03% | 6.14% |
| No trade history for SmartShares funds — their underlying ETFs are passive index trackers, so day-to-day rebalancing is minimal. | |||||